Sam joined MedImmune Venture’s West Coast Office in September of 2010 from SV Life Sciences, where he was a principle for eight years, investing and working with a broad range of biopharmaceutical, platform and medical device companies. Previously, he was an Engagement Manager with McKinsey and Company’s Pharmaceuticals and Medical Products practice, where he led teams of consultants serving clients on M&A, portfolio analysis and other strategic issues.
Sam holds an A.B. magna cum laude in Biochemistry from Harvard College, attended Stanford University School of Medicine where he earned an M.D. and a Ph.D. in Biochemistry as a Howard Hughes Predoctoral Fellow, and trained in Internal Medicine at the University of California, Los Angeles.